Significantly, a recent meta-analysis by Bayleyegn et al. showed that multiple coagulation factors, including PT, D-dimer, fibrinogen, and platelets, were higher in lung cancer patients compared to controls, suggesting they could even provide a clue for early diagnosis or aid risk stratification [40]. This evidence concerns the gene F2 and lung cancer.